Financials Grifols, S.A.

Equities

GRF

ES0171996087

Pharmaceuticals

Market Closed - BME 12:42:41 2025-03-21 pm EDT 5-day change 1st Jan Change
9.200 EUR -2.13% Intraday chart for Grifols, S.A. -2.02% +0.57%

Projected Income Statement: Grifols, S.A.

Forecast Balance Sheet: Grifols, S.A.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 6,436 6,695 9,158 9,337 9,187 9,128 8,381 8,082
Change - 4.02% 36.79% 1.95% -1.61% -0.64% -8.18% -3.57%
Announcement Date 2/26/21 2/28/22 2/28/23 2/28/24 2/26/25 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Grifols, S.A.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 308.1 280.9 266.5 295.4 371.4 375.8 375.7 398
Change - -8.83% -5.13% 10.86% 25.71% 1.21% -0.03% 5.92%
Free Cash Flow (FCF) 1 802.2 316.1 -277.4 -87.14 530.8 796.7 868.9 1,206
Change - -60.6% -187.75% -68.58% -709.16% 50.09% 9.06% 38.84%
Announcement Date 2/26/21 2/28/22 2/28/23 2/28/24 2/26/25 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Grifols, S.A.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 27.7% 19.49% 20.14% 22.07% 24.67% 25.22% 26.93% 27.55%
EBIT Margin (%) 18.65% 12.06% 13.29% 15.52% 18.81% 18.29% 20.3% 20.96%
EBT Margin (%) 16.45% 7.1% 5.96% 3.4% 6.16% 9.91% 12.45% 13.7%
Net margin (%) 11.58% 3.71% 3.43% 0.9% 2.18% 6.05% 8.3% 9.32%
FCF margin (%) 15.02% 6.41% -4.57% -1.32% 7.36% 10.29% 10.5% 13.64%
FCF / Net Income (%) 129.7% 172.91% -133.17% -146.91% 338.26% 169.99% 126.53% 146.33%

Profitability

        
ROA 4.01% 1.06% 1.02% 1.04% 0.74% 2.1% 3.55% 3.2%
ROE 12.46% 3.26% 3.57% 3.72% 2.79% 8.71% 10.64% 11.53%

Financial Health

        
Leverage (Debt/EBITDA) 4.35x 6.96x 7.5x 6.42x 5.16x 4.68x 3.76x 3.32x
Debt / Free cash flow 8.02x 21.18x -33.02x -107.16x 17.31x 11.46x 9.65x 6.7x

Capital Intensity

        
CAPEX / Current Assets (%) 5.77% 5.69% 4.39% 4.48% 5.15% 4.86% 4.54% 4.5%
CAPEX / EBITDA (%) 20.83% 29.21% 21.83% 20.31% 20.87% 19.25% 16.87% 16.33%
CAPEX / FCF (%) 38.4% 88.86% -96.08% -339.03% 69.96% 47.18% 43.24% 32.99%

Items per share

        
Cash flow per share 1 1.616 0.8759 -0.016 0.3076 1.327 1.117 1.443 1.684
Change - -45.78% -101.83% -2,022.5% 331.37% -15.78% 29.11% 16.7%
Dividend per Share 1 0.17 0.36 - - - 0.0114 0.1968 0.3535
Change - 111.76% - - - - 1,629.26% 79.64%
Book Value Per Share 1 11.99 8.945 9.036 8.638 8.657 9.354 10.24 11.33
Change - -25.38% 1.01% -4.41% 0.22% 8.05% 9.45% 10.66%
EPS 1 0.9 0.27 0.31 0.09 0.23 0.6868 1.023 1.235
Change - -70% 14.81% -70.97% 155.56% 198.62% 48.94% 20.73%
Nbr of stocks (in thousands) 684,540 682,484 678,911 678,665 679,629 680,409 680,409 680,409
Announcement Date 2/26/21 2/28/22 2/28/23 2/28/24 2/26/25 - - -
1EUR
Estimates
2025 *2026 *
P/E ratio 13.4x 8.99x
PBR 0.98x 0.9x
EV / Sales 1.92x 1.7x
Yield 0.12% 2.14%
More valuation ratios * Estimated data

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
9.200EUR
Average target price
16.42EUR
Spread / Average Target
+78.49%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. GRF Stock
  4. Financials Grifols, S.A.